autodock

bfe67bb53c3c532ef4237fa3323691ae27404769

AutoDock - Molecular Docking Software

Overview

AutoDock is a suite of automated molecular docking software developed by the Olson Laboratory at the Scripps Research Institute. It predicts how small molecules (ligands) bind to macromolecular targets (proteins, nucleic acids) by exploring binding modes and estimating binding affinity. AutoDock is widely used in structure-based drug design for neurodegenerative disease therapeutic development.

Suite Components

AutoDock4 (AD4)

The classic Lamarckian genetic algorithm implementation:

• Search algorithm: Lamarckian genetic algorithm (LGA)
• Scoring function: Force-field based with desolvation terms
• Flexibility: Partial ligand and receptor flexibility
• Use case: General-purpose docking for drug discovery

AutoDock Vina (Vina)

Modern, high-performance docking program:

• Speed: 10-100x faster than AD4 through GPU acceleration
• Scoring: Knowledge-based scoring function trained on PDBbind
• Accuracy: Competitive with gold-standard methods
• Use case: High-throughput virtual screening

AutoDock4Zn (AD4Zn)

Optimized force field for metal-containing proteins:

• Zn parameters: Improved treatment of Zn²⁺ in metalloproteins
• Neurodegeneration relevance: Critical for proteins with Zn binding sites (HDACs, metalloproteases)
• Use case: Docking to metalloproteins

Applications in Neurodegeneration Drug Discovery

Amyloid-Targeted Drug Design

...

bfe67bb53c3c532ef4237fa3323691ae27404769

AutoDock - Molecular Docking Software

Overview

AutoDock is a suite of automated molecular docking software developed by the Olson Laboratory at the Scripps Research Institute. It predicts how small molecules (ligands) bind to macromolecular targets (proteins, nucleic acids) by exploring binding modes and estimating binding affinity. AutoDock is widely used in structure-based drug design for neurodegenerative disease therapeutic development.

Suite Components

AutoDock4 (AD4)

The classic Lamarckian genetic algorithm implementation:

• Search algorithm: Lamarckian genetic algorithm (LGA)
• Scoring function: Force-field based with desolvation terms
• Flexibility: Partial ligand and receptor flexibility
• Use case: General-purpose docking for drug discovery

AutoDock Vina (Vina)

Modern, high-performance docking program:

• Speed: 10-100x faster than AD4 through GPU acceleration
• Scoring: Knowledge-based scoring function trained on PDBbind
• Accuracy: Competitive with gold-standard methods
• Use case: High-throughput virtual screening

AutoDock4Zn (AD4Zn)

Optimized force field for metal-containing proteins:

• Zn parameters: Improved treatment of Zn²⁺ in metalloproteins
• Neurodegeneration relevance: Critical for proteins with Zn binding sites (HDACs, metalloproteases)
• Use case: Docking to metalloproteins

Applications in Neurodegeneration Drug Discovery

Amyloid-Targeted Drug Design

AutoDock has been extensively used for Aβ-targeted drug discovery:

• γ-Secretase modulators: Docking to PSEN1/PSEN2 binding pockets to predict SARM activity
• Aβ aggregation inhibitors: Virtual screening of small molecules against Aβ fibril structures
• Anti-aggregation compounds: Predicted binding modes for known aggregation inhibitors (curcumin, flavonoids)

Alpha-Synuclein Aggregation Inhibitors

Structure-based design for PD therapeutics:

• NACore targeting: Docking to the NAC domain of alpha-synuclein involved in aggregation
• Small molecule screening: Virtual screening of natural product libraries
• Peptide design: Docking of engineered peptides that block aggregation

Kinase Inhibitor Optimization

Tau kinase drug programs use AutoDock for:

• GSK3B inhibitors: Docking-based optimization of ATP-competitive and allosteric inhibitors
• CDK5 inhibitors: Selectivity profiling across CDK family members
• DYRK1A inhibitors: Targeting dual-specificity kinases implicated in tau pathology

Neurotrophic Factor Mimetics

Small molecule NGF/BDNF mimetic development:

• Trk receptor agonists: Docking to TrkA/B/C kinase domains
• Small molecule neurotrophins: Virtual screening for Trk activation
• BDNF loop mimetics: Design of peptidomimetics based on BDNF loop regions

Virtual Screening Workflow

Step 1: Prepare Protein Structure

Step 2: Prepare Ligand Library

Step 3: Define Binding Site

Step 4: Perform Docking

Step 5: Analyze Results

Key Parameters for Neurodegeneration Targets

Grid Box Dimensions

| Target | Center (x,y,z) | Size (x,y,z) | Notes |
|--------|---------------|--------------|-------|
| GSK3B ATP site | 46.5, 53.0, 52.3 | 22, 22, 22 | Kinase hinge region |
| AChE peripheral | 5.9, 65.4, 44.5 | 20, 20, 20 | Near active site gorge |
| BACE1 S1/S2 | 10.8, 40.0, 32.0 | 26, 26, 26 | Large flap-open pocket |

Exhaustiveness Settings

• Quick screening: exhaustiveness=8 (fast virtual screening)
• Standard docking: exhaustiveness=32 (balanced speed/accuracy)
• High-precision: exhaustiveness=64 (for critical targets)

Key Publications

[AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility](https://doi.org/10.1002/jcc.21253)

[AutoDock Vina: Improving the speed and accuracy of docking](https://doi.org/10.1002/jcc.21334)

[AutoDock4Zn: Improved docking of zinc-binding compounds](https://doi.org/10.1021/ci500137z)

[Virtual screening of pharmaceutical compound libraries for neurodegeneration targets](https://doi.org/10.1021/acs.jcim.8b00382)

See Also

• [NAMD Molecular Dynamics](/technologies/namd) — Simulation complement
• [GROMACS for Molecular Dynamics](/technologies/gromacs) — MD simulation
• [AlphaFold for Protein Structure](/technologies/alphafold) — Structure prediction
• [Neurodegeneration Drug Discovery](/treatments/)
• [Tau Kinase Inhibitors](/therapeutics/tau-kinase-inhibitors)